Marker Therapeutics, Inc.MRKRNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
50.23%
↑ 164% above average
Average (39q)
-78.23%
Historical baseline
Range
High:225.77%
Low:-2989.33%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 50.23% |
| Q2 2025 | 9.69% |
| Q1 2025 | -15.86% |
| Q4 2024 | -66.27% |
| Q3 2024 | -5.26% |
| Q2 2024 | 8.36% |
| Q1 2024 | 14.64% |
| Q4 2023 | 6.00% |
| Q3 2023 | -218.53% |
| Q2 2023 | 150.64% |
| Q1 2023 | -28.81% |
| Q4 2022 | 44.27% |
| Q3 2022 | 25.15% |
| Q2 2022 | 6.72% |
| Q1 2022 | -1.51% |
| Q4 2021 | 21.45% |
| Q3 2021 | -13.96% |
| Q2 2021 | -24.23% |
| Q1 2021 | -3.20% |
| Q4 2020 | -15.41% |
| Q3 2020 | -16.24% |
| Q2 2020 | 2.22% |
| Q1 2020 | -27.69% |
| Q4 2019 | 6.96% |
| Q3 2019 | 1.99% |
| Q2 2019 | -4.72% |
| Q1 2019 | 96.08% |
| Q4 2018 | -2989.33% |
| Q3 2018 | 8.83% |
| Q2 2018 | -50.59% |
| Q1 2018 | -19.12% |
| Q4 2017 | 32.69% |
| Q3 2017 | -110.57% |
| Q2 2017 | 21.78% |
| Q1 2017 | -53.46% |
| Q4 2016 | 25.01% |
| Q3 2016 | -135.20% |
| Q2 2016 | 225.77% |
| Q1 2016 | 72.26% |
| Q4 2015 | -160.07% |